Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Hillebrandt-Roeffen, Melissa H. S.
43  Ergebnisse:
Personensuche X
?
1

Establishment and characterization of the first patient-der..:

Versleijen-Jonkers, Yvonne M. H. ; Hillebrandt-Roeffen, Melissa H. S. ; Weidema, Marije E....
Scientific Reports.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
2

Prognostic Factors in Epithelioid Hemangioendothelioma: Ana..:

Tomassen, Tess ; Versleijen-Jonkers, Yvonne M. H. ; Hillebrandt-Roeffen, Melissa H. S....
Cancers.  15 (2023)  13 - p. 3304 , 2023
Link: https://doi.org/10.3390/..
 
?
3

SLC7A8 coding for LAT2 is associated with early disease pro..:

Hurkmans, Evelien G. E. ; Koenderink, Jan B. ; van den Heuvel, Jeroen J. M. W....
Frontiers in Pharmacology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
4

Targeting the FAK-Src Complex in Desmoplastic Small Round C..:

van Erp, Anke E. M. ; Hillebrandt-Roeffen, Melissa H. S. ; van Bree, Niek F. H. N....
Sarcoma.  2022 (2022)  - p. 1-17 , 2022
Link: https://doi.org/10.1155/..
 
?
5

Immunological and Genomic Analysis Reveals Clinically Relev..:

van Ravensteijn, Stefan G. ; Versleijen-Jonkers, Yvonne M. H. ; Hillebrandt-Roeffen, Melissa H. S....
Cancers.  14 (2022)  23 - p. 5938 , 2022
Link: https://doi.org/10.3390/..
 
?
6

PARP inhibition in UV-associated angiosarcoma preclinical m..:

Weidema, Marije E. ; Desar, Ingrid M. E. ; Hillebrandt-Roeffen, Melissa H. S....
Journal of Cancer Research and Clinical Oncology.  147 (2021)  9 - p. 2579-2590 , 2021
Link: https://doi.org/10.1007/..
 
?
7

Immunohistochemical selection of biomarkers for tumor-targe..:

de Gooyer, Jan Marie ; Versleijen-Jonkers, Yvonne M. H. ; Hillebrandt-Roeffen, Melissa H. S....
Scientific Reports.  10 (2020)  1 - p. , 2020
Link: https://doi.org/10.1038/..
 
?
8

Olaparib and temozolomide in desmoplastic small round cell ..:

van Erp, Anke E. M. ; van Houdt, Laurens ; Hillebrandt-Roeffen, Melissa H. S....
Journal of Cancer Research and Clinical Oncology.  146 (2020)  7 - p. 1659-1670 , 2020
Link: https://doi.org/10.1007/..
 
?
9

Prognostic Factors in a Large Nationwide Cohort of Histolog..:

Weidema, Marije E. ; Flucke, Uta E. ; van der Graaf, Winette T.A....
Cancers.  11 (2019)  11 - p. 1780 , 2019
Link: https://doi.org/10.3390/..
 
?
10

Expression and clinical association of programmed cell deat..:

van Erp, Anke E.M. ; Versleijen-Jonkers, Yvonne M.H. ; Hillebrandt-Roeffen, Melissa H.S....
Oncotarget.  8 (2017)  41 - p. 71371-71384 , 2017
Link: https://doi.org/10.18632..
 
?
11

Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarc..:

van Erp, Anke E. M. ; Hillebrandt-Roeffen, Melissa H. S. ; van Houdt, Laurens...
Targeted Oncology.  12 (2017)  6 - p. 815-826 , 2017
Link: https://doi.org/10.1007/..
 
?
12

Targeting Cyclin-Dependent Kinases in Synovial Sarcoma: Pal..:

Vlenterie, Myrella ; Hillebrandt-Roeffen, Melissa H. S. ; Schaars, Esther W. M....
Annals of Surgical Oncology.  23 (2016)  9 - p. 2745-2752 , 2016
Link: https://doi.org/10.1245/..
 
?
13

Next generation sequencing in synovial sarcoma reveals nove..:

Vlenterie, Myrella ; Hillebrandt-Roeffen, Melissa H.S. ; Flucke, Uta E....
Oncotarget.  6 (2015)  33 - p. 34680-34690 , 2015
Link: https://doi.org/10.18632..
 
?
14

The role of AXL and the in vitro activity of the receptor t..:

Fleuren, Emmy D.G. ; Hillebrandt-Roeffen, Melissa H.S. ; Flucke, Uta E....
Oncotarget.  5 (2014)  24 - p. 12753-12768 , 2014
Link: https://doi.org/10.18632..
 
?
15

SLC7A8 coding for LAT2 is associated with early disease pro..:

Hurkmans, E.G.E. (Evelien) ; Koenderink, J.B. (Jan B.) ; Heuvel, J.J.M.W. (Jeroen J. M. W.) van den...
https://pubmed.ncbi.nlm.nih.gov/36438828/.  , 2022
Link: https://hdl.handle.net/1..
 
1-15